BACKGROUND AND OBJECTIVES: We analysed the frequency and predictors of delayed access to care (DAC) for HIV infection, and its influence on survival. METHODS: We studied predictors of DAC among 18,721 patients enrolled between 1997 and 2002 in the French Hospital Database on HIV (FHDH), DAC being defined by a CD4* T-cell count below 200 copies/mm3 and/or AIDS at FHDH enrollment. The association of DAC with the initiation of combined antiretroviral therapy (cART) and of DAC with survival were analysed with Cox multivariable models. RESULTS: The overall prevalence of DAC was 35.7%. Compared with patients under 30 years of age, patients over 60 were 3.5 times more likely to have DAC (P < 10(-4)). Compared with non-migrant women, odds ratios (OR) of DAC were higher among migrant women (1.5), non-migrant men (1.6) and migrant men (1.9; all P < 10(-4)). Compared with men who have sex with men, other transmission groups had an estimated OR for DAC of 1.6 (P < 10(-4)). DAC was more frequent among patients with a recent diagnosis of HIV infection [OR = 1.3, 95% confidence intervals (CI) = (1.2;1.4)]. Patients with DAC received cART earlier than other patients [hazard ratio (HR) = 2.2, 95% CI = (2.1;2.3)]. The DAC/mortality HR was 13.9 in the first 6 months after enrollment in the FHDH, and remained significantly higher than 1 during the subsequent 4 years. CONCLUSION: DAC is common in France and was associated with a higher mortality, despite early initiation of cART. Earlier access to care and specific clinical management of patients with DAC should be considered.
BACKGROUND AND OBJECTIVES: We analysed the frequency and predictors of delayed access to care (DAC) for HIV infection, and its influence on survival. METHODS: We studied predictors of DAC among 18,721 patients enrolled between 1997 and 2002 in the French Hospital Database on HIV (FHDH), DAC being defined by a CD4* T-cell count below 200 copies/mm3 and/or AIDS at FHDH enrollment. The association of DAC with the initiation of combined antiretroviral therapy (cART) and of DAC with survival were analysed with Cox multivariable models. RESULTS: The overall prevalence of DAC was 35.7%. Compared with patients under 30 years of age, patients over 60 were 3.5 times more likely to have DAC (P < 10(-4)). Compared with non-migrant women, odds ratios (OR) of DAC were higher among migrant women (1.5), non-migrant men (1.6) and migrant men (1.9; all P < 10(-4)). Compared with men who have sex with men, other transmission groups had an estimated OR for DAC of 1.6 (P < 10(-4)). DAC was more frequent among patients with a recent diagnosis of HIV infection [OR = 1.3, 95% confidence intervals (CI) = (1.2;1.4)]. Patients with DAC received cART earlier than other patients [hazard ratio (HR) = 2.2, 95% CI = (2.1;2.3)]. The DAC/mortality HR was 13.9 in the first 6 months after enrollment in the FHDH, and remained significantly higher than 1 during the subsequent 4 years. CONCLUSION: DAC is common in France and was associated with a higher mortality, despite early initiation of cART. Earlier access to care and specific clinical management of patients with DAC should be considered.
Authors: Caroline E Sloan; Karen Champenois; Philippe Choisy; Elena Losina; Rochelle P Walensky; Bruce R Schackman; Faiza Ajana; Hugues Melliez; A D Paltiel; Kenneth A Freedberg; Yazdan Yazdanpanah Journal: AIDS Date: 2012-01-02 Impact factor: 4.177
Authors: Latesha Elopre; Andrew O Westfall; Michael J Mugavero; Anne Zinski; Greer Burkholder; Edward W Hook; Nicholas Van Wagoner Journal: AIDS Behav Date: 2016-01
Authors: Véronique Joly; Catherine Fagard; Carine Grondin; Diane Descamps; Yazdan Yazdanpanah; Charlotte Charpentier; Nathalie Colin de Verdiere; Sophie Tabuteau; François Raffi; André Cabie; Geneviève Chene; Patrick Yeni Journal: Antimicrob Agents Chemother Date: 2012-11-19 Impact factor: 5.191
Authors: Susie Hoffman; Yingfeng Wu; Maria Lahuerta; Sarah Gorrell Kulkarni; Harriet Nuwagaba-Biribonwoha; Wafaa El Sadr; Robert H Remien; Veronicah Mugisha; Mark Hawken; Ema Chuva; Denis Nash; Batya Elul Journal: AIDS Date: 2014-10-23 Impact factor: 4.177
Authors: Denise Jaworsky; Laverne Monette; Janet Raboud; Doe O'Brien-Teengs; Christina Diong; Sandra Blitz; Sean B Rourke; Mona R Loutfy Journal: Can J Infect Dis Med Microbiol Date: 2012 Impact factor: 2.471